前立腺癌に対するEstramustine Phosphate(Estracyt)の使用経験

概要

論文の詳細を見る
Estramustine phosphate (Estracyt) was administered to 15 patients with prostatic carcinoma and its therapeutic effects were followed. 1. We were able to evaluate IO patients, in primary treatment for 11 patients. Good clinical response was obtained in these 10 patients. 2. Good clinical response was obtained in one of 4 patients having resistance to hormone therapy. 3. Gynecomastia and gastro-intestinal symptom were observed frequently and hepatotoxicity, anemia, thrombocytopenia and massive edema were observed in one case respectively.